Delivery Order SPE2DB24D1007-SPE2DB25FCCAV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,677.02 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025, and carries no set-aside designation. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a $11,924.99 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes management medication. The contract was competitively awarded without set-aside designation and carries a firm fixed-price structure with an ultimate completion date of August 5, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,482.71 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, a diabetes medication. This firm fixed price delivery order, awarded on September 12, 2025, with a completion date of September 15, 2025, was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,395.43 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 10 mg, an oral diabetes medication. The contract was competitively awarded on July 21, 2025, with a completion date of July 22, 2025, using firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,624.71 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. This non-competitive, firm fixed-price delivery order was awarded on August 5, 2025, with an ultimate completion date of August 6, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract issued under...
- The Defense Logistics Agency awarded a $5,669.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication, with an ultimate completion date of July 25, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded through open procurement. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order valued at $6,274.92 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes management medication. This non-competitive delivery order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price transaction fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The award is classified as a child contract, indicating it derives from a larger...
- The Defense Logistics Agency awarded a $7,177.68 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $7,460.56 to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract, awarded on July 22, 2025, with completion targeted for July 23, 2025, utilizes a firm fixed-price delivery order structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement...
- The Defense Logistics Agency awarded a $7,108.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Jardiance 25 mg, a diabetes medication. The contract was competitively awarded without set-aside designation and has an ultimate completion date of August 11, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB25FCCAVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,987.19 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 10 mg, a diabetes medication. The contract, awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor and critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive prime vendor contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and the U.S. Coast Guard. The contractor's demonstrated capability to meet federal procurement requirements through multiple therapeutic domains and delivery mechanisms positions it as a key pharmaceutical supplier within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.0k | 6/2/25 |